In this episode, Hall welcomes Jak Knowles, Vice President Venture Investments and Head of Pharma at Leaps by Bayer. 

Leaps by Bayer was “created in 2015 to break boundaries in life sciences investment—in scale, risk, collaboration, and mission.” Since 2015, Leaps by Bayer has invested over $800M in ventures that tackle fundamental breakthroughs and shift core paradigms in their industries.

Jak began his career in the medical field, but shifted to equities research at an investment bank and then on to venture capital. Leaps’ main focus is biotech, with some investments solely on the tech side.

Jak speaks about some of the companies that Leaps by Bayer have invested in, gives advice to investors and entrepreneurs, and speaks about the challenges on both sides.

Visit Leaps by Bayer at www.leaps.bayer.com/

Jak can be contacted via LinkedIn at www.linkedin.com/in/jak-knowles-8b0bb83b/ or via email at jak.knowles@bayer.com.  

Copyright (c) 2024, Hall Martin and investorconnect.org. All rights reserved.

Disclaimer:
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.